| Code | Description | Claims | Beneficiaries | Total Paid |
| X4011 |
State-specific procedure code |
34,165 |
31,882 |
$14.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
83,666 |
80,771 |
$14.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
35,550 |
33,591 |
$7.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,333 |
20,795 |
$6.20M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,962 |
16,841 |
$2.25M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
77,015 |
71,529 |
$2.20M |
| 80053 |
Comprehensive metabolic panel |
71,273 |
66,515 |
$1.94M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
18,781 |
18,397 |
$1.80M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29,660 |
27,382 |
$1.47M |
| 81001 |
|
31,339 |
29,860 |
$1.30M |
| Y7507 |
|
5,820 |
5,211 |
$1.18M |
| 81025 |
|
20,407 |
19,651 |
$1.17M |
| 71045 |
Radiologic examination, chest; single view |
21,663 |
20,042 |
$887K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,265 |
2,193 |
$763K |
| 87631 |
|
2,266 |
2,232 |
$703K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
10,592 |
10,407 |
$557K |
| 71046 |
Radiologic examination, chest; 2 views |
2,836 |
2,730 |
$411K |
| X4006 |
|
613 |
526 |
$403K |
| 84484 |
|
18,035 |
15,677 |
$400K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,716 |
1,669 |
$386K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,006 |
1,898 |
$381K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,443 |
3,299 |
$360K |
| Y7506 |
|
1,187 |
1,081 |
$347K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,687 |
7,292 |
$330K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,778 |
1,714 |
$269K |
| 83690 |
|
9,346 |
8,942 |
$257K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,443 |
6,827 |
$254K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,276 |
1,259 |
$246K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,013 |
3,705 |
$243K |
| 87070 |
|
792 |
780 |
$213K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,871 |
5,499 |
$194K |
| 81003 |
|
8,207 |
7,810 |
$160K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,595 |
2,443 |
$157K |
| 87807 |
|
457 |
445 |
$129K |
| 83880 |
|
3,723 |
3,491 |
$124K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,946 |
3,480 |
$109K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,146 |
3,967 |
$106K |
| 82150 |
|
1,061 |
1,018 |
$94K |
| X4003 |
|
1,480 |
1,336 |
$91K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
683 |
623 |
$90K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,892 |
2,782 |
$90K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,821 |
2,716 |
$89K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
597 |
556 |
$79K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,679 |
707 |
$75K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
612 |
608 |
$63K |
| 80061 |
Lipid panel |
5,066 |
4,951 |
$63K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
618 |
293 |
$53K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,679 |
3,573 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
837 |
779 |
$44K |
| 83735 |
|
2,842 |
2,739 |
$44K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
586 |
564 |
$34K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
518 |
503 |
$34K |
| 85610 |
|
1,068 |
1,006 |
$24K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
612 |
608 |
$22K |
| 87808 |
|
471 |
459 |
$21K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,277 |
2,837 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,579 |
2,540 |
$20K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
319 |
316 |
$19K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,084 |
919 |
$18K |
| J3490 |
Unclassified drugs |
10,837 |
8,004 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
804 |
788 |
$17K |
| 84702 |
|
867 |
835 |
$17K |
| 82077 |
|
1,551 |
1,412 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
119 |
99 |
$11K |
| 97161 |
|
360 |
330 |
$8K |
| 85730 |
|
294 |
276 |
$8K |
| 87077 |
|
327 |
316 |
$8K |
| 62323 |
|
106 |
95 |
$7K |
| 83605 |
|
957 |
873 |
$7K |
| 85379 |
|
638 |
603 |
$7K |
| 84439 |
|
955 |
934 |
$6K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
13 |
$6K |
| 74019 |
|
25 |
25 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
55 |
50 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
40 |
37 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
147 |
146 |
$4K |
| 87536 |
|
67 |
65 |
$4K |
| 80143 |
|
274 |
249 |
$3K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
157 |
25 |
$3K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
161 |
160 |
$3K |
| 82043 |
|
498 |
485 |
$3K |
| 80179 |
|
206 |
184 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
75 |
37 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
14 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
76 |
74 |
$2K |
| 87510 |
|
121 |
115 |
$2K |
| 87480 |
|
121 |
115 |
$2K |
| 84550 |
|
643 |
635 |
$2K |
| 94010 |
|
31 |
29 |
$2K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
49 |
49 |
$2K |
| 82570 |
|
464 |
453 |
$2K |
| 87660 |
|
109 |
104 |
$2K |
| 80050 |
General health panel |
71 |
70 |
$2K |
| 20610 |
|
16 |
12 |
$2K |
| 73630 |
|
24 |
24 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,342 |
4,688 |
$2K |
| 73564 |
|
29 |
26 |
$2K |
| 85027 |
|
332 |
325 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
26 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
66 |
64 |
$1K |
| 62368 |
|
27 |
26 |
$1K |
| 76830 |
Ultrasound, transvaginal |
13 |
12 |
$1K |
| 82607 |
|
101 |
98 |
$984.43 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
16 |
12 |
$946.03 |
| 72100 |
|
106 |
103 |
$804.60 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
14 |
$718.45 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
28 |
27 |
$651.24 |
| 73610 |
|
12 |
12 |
$595.83 |
| 87040 |
|
41 |
39 |
$479.98 |
| 73030 |
|
14 |
12 |
$462.92 |
| 86706 |
|
45 |
45 |
$397.47 |
| 88342 |
|
13 |
12 |
$381.43 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
30 |
29 |
$361.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12 |
12 |
$330.96 |
| 86704 |
|
31 |
31 |
$301.64 |
| 82550 |
|
54 |
51 |
$277.72 |
| 87340 |
|
29 |
29 |
$239.50 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
79 |
78 |
$187.50 |
| 86300 |
|
12 |
12 |
$183.04 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
13 |
$129.49 |
| 73130 |
|
14 |
12 |
$105.16 |
| 86803 |
|
12 |
12 |
$102.69 |
| 82010 |
|
12 |
12 |
$69.84 |
| 86592 |
|
16 |
16 |
$69.32 |
| 87184 |
|
12 |
12 |
$39.72 |
| 85049 |
|
12 |
12 |
$39.70 |
| 82962 |
|
12 |
12 |
$25.97 |
| 86901 |
|
15 |
13 |
$22.94 |
| 85048 |
|
12 |
12 |
$22.54 |
| 86900 |
|
15 |
13 |
$22.36 |
| 85018 |
|
12 |
12 |
$20.99 |
| 85014 |
|
12 |
12 |
$20.99 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
18 |
14 |
$5.82 |
| 97116 |
|
27 |
13 |
$3.47 |
| A4215 |
Needle, sterile, any size, each |
51 |
48 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
25 |
25 |
$0.00 |
| C1755 |
Catheter, intraspinal |
28 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
21 |
20 |
$0.00 |